Therapy Areas: Vaccines
US Centers for Disease Control and Prevention and US Food and Drug Administration advise US pause of Johnson & Johnson COVID-19 vaccine due to concerns about blood clots
13 April 2021 -

The US Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA) have recommended that the US pause the use of Johnson & Johnson's COVID-19 vaccine because of six reported US cases of a rare and severe type of blood clot, CNN news company reported on Tuesday.

According to European health authorities, there have been "four serious cases of unusual blood clots" reported in people who were given the Johnson & Johnson vaccine and like their US counterparts, the European authorities are investigating these cases and that "it is currently not clear" whether there's a causal association between the vaccine and the clots, CNN added.

US health officials are encouraging Americans to get vaccinated as soon as they can, however there are concerns that news coverage about clots being studied in relation to Johnson & Johnson's vaccine might make some Americans more hesitant to get vaccinated for COVID-19.